Literature DB >> 19125672

In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment.

Eliane Bourreau1, Catherine Ronet, Edith Darsissac, Marie-Claire Lise, Dominique Sainte Marie, Emmanuel Clity, Fabienne Tacchini-Cottier, Pierre Couppie, Pascal Launois.   

Abstract

The presence of intralesional natural regulatory T cells, characterized by the expression of Foxp3 mRNA, was analyzed in patients with localized leishmaniasis due to Leishmania guyanensis infection that was unresponsive to treatment with pentamidine isethionate. Foxp3 mRNA levels were associated with unresponsiveness to treatment among patients with a lesion duration of 1 month, but this association was not observed among patients with a lesion duration of <1 month. In conclusion, high intralesional expression of Foxp3 might be an indicator of poor response to treatment, depending on the duration of lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125672     DOI: 10.1086/596508

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.

Authors:  Nicolas Barros; Nestor Vasquez; Fernando Woll; Cesar Sanchez; Braulio Valencia; Alejandro Llanos-Cuentas; A Clinton White; Martin Montes
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

3.  Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen.

Authors:  R Maurya; R Kumar; V K Prajapati; K D Manandhar; D Sacks; S Sundar; S Nylén
Journal:  Parasite Immunol       Date:  2010-07       Impact factor: 2.280

Review 4.  Smuggling across the border: how arthropod-borne pathogens evade and exploit the host defense system of the skin.

Authors:  Quentin Bernard; Benoit Jaulhac; Nathalie Boulanger
Journal:  J Invest Dermatol       Date:  2013-12-28       Impact factor: 8.551

Review 5.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

6.  Clinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis.

Authors:  Andrea K Boggild; Ana P Ramos; Diego Espinosa; Braulio M Valencia; Nicolas Veland; Cesar Miranda-Verastegui; Jorge Arevalo; Donald E Low; Alejandro Llanos-Cuentas
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

7.  Murine model of chronic L. (Viannia) panamensis infection: role of IL-13 in disease.

Authors:  Tiago M Castilho; Karen Goldsmith-Pestana; Caterin Lozano; Liliana Valderrama; Nancy G Saravia; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

8.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

9.  Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.

Authors:  E Bourreau; C Ronet; E Darcissac; M C Lise; D Sainte Marie; E Clity; F Tacchini-Cottier; P Couppie; P Launois
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

10.  miR-548d-3p Alters Parasite Growth and Inflammation in Leishmania (Viannia) braziliensis Infection.

Authors:  Marina de Assis Souza; Eduardo Milton Ramos-Sanchez; Sandra Márcia Muxel; Dimitris Lagos; Luiza Campos Reis; Valéria Rêgo Alves Pereira; Maria Edileuza Felinto Brito; Ricardo Andrade Zampieri; Paul Martin Kaye; Lucile Maria Floeter-Winter; Hiro Goto
Journal:  Front Cell Infect Microbiol       Date:  2021-06-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.